- Oxford Biomedica PLC oxford Biomedica to host webinar showcasing the TetraVectaTM system TranscriptOct 02, 2023
- Half Year 2023 Oxford Biomedica PLC Earnings Call TranscriptSep 20, 2023$3.49 (+11.86%)Earnings
- Full Year 2022 Oxford Biomedica PLC Earnings Call TranscriptApr 25, 2023$5.53Earnings
- Oxford Biomedica PLC at JPMorgan Healthcare Conference TranscriptJan 09, 2023
- Half Year 2022 Oxford BioMedica PLC Earnings Call TranscriptSep 15, 2022$5.21 (+0.29%)Earnings
- Full Year 2021 Oxford BioMedica PLC Earnings Call TranscriptApr 20, 2022$7.1 (-15.98%)Earnings
- Half Year 2021 Oxford BioMedica PLC Earnings Call TranscriptSep 22, 2021$22.64 (+17.82%)Earnings
- Full Year 2020 Oxford BioMedica PLC Earnings Call TranscriptApr 15, 2021$14.81 (+4.19%)Earnings
- Half Year 2020 Oxford BioMedica PLC Earnings Call TranscriptSep 17, 2020$11.24 (+2.18%)Earnings
- Oxford BioMedica PLC Annual Shareholders Meeting TranscriptJun 23, 2020
- Full Year 2019 Oxford BioMedica PLC Earnings Call TranscriptMay 06, 2020$8.93 (-2.40%)Earnings
- Half Year 2019 Oxford BioMedica PLC Earnings Call TranscriptSep 04, 2019$7.8Earnings
- Full Year 2018 Oxford BioMedica PLC Earnings Call TranscriptMar 14, 2019$9.15Earnings
Half Year 2019 Oxford BioMedica PLC Earnings Call Transcript
Ladies and gentlemen, thank you for standing by, and welcome to the Oxford Biomedica interim results for the 6 months ended 2019 -- June 2019. (Operator Instructions) I must advise you that this conference is being recorded today, Wednesday the 4th of September, 2019. (Operator Instructions)
Good afternoon, and welcome to Oxford Biomedica's interim results for the 6 months ending the 30th of June, 2019. I'd like to thank everybody in the room for joining us today as well as those on the line.
The first half of the year has been a very busy year for Oxford Biomedica. We signed collaborations with Microsoft and Santen, and the expansion of our manufacturing facilities is continuing very well and is progressing as planned, to be completed by the end of the year.
Financially, our balance sheet is on a far firmer footing. We have paid down our GBP 43 million loan. And we have a new investor, Novo Holdings; they invested GBP 53 million. Through this growth in our
Access to All Earning Calls and Stock Analysis | |
30-Year Financial on one screen | |
All-in-one Stock Screener with unlimited filters | |
Customizable Stock Dashboard | |
Real Time Insider Trading Transactions | |
8,000+ Institutional investors’ 13F holdings | |
Powerful Excel Add-in and Google sheets Add-on | |
All data downloadable | |
Quick customer support | |
And much more... |
![](https://static.gurufocus.com/material/money-back-guarantee.png)
![](https://static.gurufocus.com/trust_rating.png)
![](https://static.gurufocus.com/trust.png)